Page 6 - Amy Wolf News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Capital Markets Day 2023 - Ipsen Outlines Next Phase Of Growth & Transformation And Provides New Mid-Term Outlook

Capital Markets Day 2023 - Ipsen Outlines Next Phase Of Growth & Transformation And Provides New Mid-Term Outlook
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomFrance generalUnited statesAmy wolfChristelle huguetIoana piscociuIpsen euronextDavid loewNicolas boglerStewart campbellMari scheiffeleBartek bednarzAymeric le chatelierCapital markets dayChief executive officer

Ipsen Pharma: Capital Markets Day 2023 - Ipsen outlines next phase of growth & transformation and provides new mid-term outlook

Ipsen Pharma: Capital Markets Day 2023 - Ipsen outlines next phase of growth & transformation and provides new mid-term outlook
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomFrance generalUnited statesStefan klotterNicolas boglerStewart campbellIoana piscociuDavid loewChristelle huguetBartek bednarzIpsen euronextAmy wolfMari scheiffeleAymeric le chatelierCapital markets day

Ipsen Pharma: Ipsen confirms U S FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC

Ipsen Pharma: Ipsen confirms U S FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomUnited statesIoana piscociuNicolas boglerStefan klotterKumagit heathcoteAnna gibbinsIpsen euronextAmy wolfChristelle huguetPascal prigentStephanie boyerEuropean medicines agencyUncertainties of the companyHead of research development

GENFIT: Results from Ipsen s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine | 13 11 23

GENFIT: Results from Ipsen s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine | 13 11 23
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

United kingdomFrance generalUnited statesIpsen euronextIoana piscociuJean christophe marcouxChristelle huguetStephanie boyerAnna gibbinsMo christieChristopher bowlusAmy wolfNicolas boglerGlobal head of franchise communicationsUniversity of california davisHead of patient services

Medison Pharma; Ipsen: Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Medison Pharma; Ipsen: Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrance generalUnited kingdomIntrahepatic cholestasisGastroenterol hepatolGil gurfinkelIoana piscociuDara willisJennifer mooreMedison pharmaWalter perezNicolas boglerAmy wolfIpsen euronextStewart campbellInbal chen